TickerFacts.

Coherus Oncology, Inc. (CHRS): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2015-12-31, 2016-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

121.15M
As of 2025-12-31
154.47M
As of 2026-06-30
+15.4%
3-year compound annual growth
+10.8%
5-year compound annual growth
2013-12-31: 4.84M2014-12-31: 33.26M2015-12-31: 39.01M2016-12-31: 45.81M2017-12-31: 59.84M2018-12-31: 68.30M2019-12-31: 70.37M2020-12-31: 72.51M2021-12-31: 76.93M2022-12-31: 78.85M2023-12-31: 112.22M2024-12-31: 115.61M2025-12-31: 121.15M121.15M
2013-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-31121.15M+4.8%2026-03-09, Balance as of period end
2024-12-31115.61M+3.0%2026-03-09, Balance as of period end
2023-12-31112.22M+42.3%2025-03-17, Balance as of period end
2022-12-3178.85M+2.5%2024-03-15, Balance as of period end
2021-12-3176.93M+6.1%2023-03-06, Balance as of period end
2020-12-3172.51M+3.1%2022-02-23, Balance as of period end
2019-12-3170.37M+3.0%2021-02-25, Balance as of period end
2018-12-3168.30M+14.1%2020-02-27, Balance as of period end
2017-12-3159.84M+30.6%2019-02-28, Balance as of period end
2016-12-3145.81Mn/c2018-03-08, Balance as of period end
2015-12-3139.01Mn/c2017-03-14, Balance as of period end
2014-12-3133.26M+587.5%2016-02-29, Balance as of period end
2013-12-314.84Mn/a2015-03-23, Balance as of period end